Richard A. King is a notable inventor based in Berkeley, California, with a remarkable portfolio of 11 patents. His work primarily focuses on advancements in medical technology, particularly in analyte detection systems that enhance patient care.

Latest Patents

Among his latest patents is a system and method for determining a treatment dose for a patient. This innovative method utilizes an analyte detection system that is coupled to the patient, allowing for the automatic measurement of analytes in bodily fluids. The results from these measurements are then used to determine appropriate treatment doses tailored to individual patients. Another significant patent involves a method for determining analyte concentration using periodic temperature modulation and phase detection. This method introduces a temperature gradient in test samples, enabling infrared radiation detectors to measure radiation at specific wavelengths. The differences in parameters between reference and analytical signals are then processed to accurately determine analyte concentration, enhancing the precision of the measurements.

Career Highlights

Richard A. King is currently associated with Optiscan Biomedical Corporation, where he continues to contribute to the field of biomedical innovations. His expertise in analyte detection systems has positioned him as a key player in developing technologies that improve health monitoring and treatment methodologies.

Collaborations

He has collaborated with notable colleagues such as Bernhard B. Sterling and James Roswell Braig, further enriching his contributions to the field through shared knowledge and expertise.

Conclusion

Richard A. King's innovative work in analyte detection systems exemplifies the intersection of technology and healthcare, showcasing his commitment to improving patient outcomes through his inventions. His contributions continue to influence the medical technology landscape significantly.

This text is generated by artificial intelligence and may not be accurate.